课题基金 / 基金详情

MHCI Inhibition of Neuronal Repair Responses

MHCI Inhibition of Neuronal Repair Responses
MHCI 抑制神经元修复反应
批准号:
6897885
负责人:
DANIEL KAUFMAN
金额:
$17.76万
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-07-01 至 2007-04-30

项目摘要

项目成果

DANIEL KAUFMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): In the immune system, MHCI is well known for its ability to suppress NK cell and T cell function, providing a key mechanism for preventing autoreactivity. MHCI expression in the CNS is generally low. However, MHCI expression is locally induced on neurons following kainate-induced seizures and CNS injury, and numerous studies have observed increases in MHCI expression in the CNS of patients with brain injury, stroke, epilepsy and neurodegenerative diseases. Recently, neuronal MHCI was shown to be involved in the elimination of inappropriate synaptic connections in the CNS. Moreover, our preliminary results indicate that MHCI can inhibit neuronal outgrowth in vitro. Based on these observations, we hypothesized that the induced expression of MHCI on neurons following injury might counteract neuronal repair responses in vivo. To test this hypothesis, we utilized a well-characterized model of compensatory neuronal sprouting that occurs following unilateral lesioning of the perforant path, combined with transgenic mice which were genetically engineered to express low levels of MHCI on CNS neurons. Our preliminary results indicate that although these transgenic mice had no apparent developmental CNS abnormalities, they have severely reduced compensatory sprouting responses following CNS injury. This proposal will further test the hypothesis that neuronal MHCI can inhibit compensatory neuronal sprouting responses. This will provide a foundation from which the role of MHCI in neurodevelopment and neuronal repair can be further assessed. This proposal opens a new area of research, the results of which may provide important conceptual advances. Conceivably, treatments that limit the neuroinhibitory effects of MHCI could lead to new clinical approaches to mitigate neuropathological disorders.
期刊论文(6)
专著(0)
科研奖励(0)
会议论文
Major histocompatibility complex class I molecules modulate embryonic neuritogenesis and neuronal polarization.
主要的组织相容性复合物I类分子调节胚胎神经发生和神经元极化。
DOI: 10.1016/j.jneuroim.2012.03.008
发表时间: 2012-06-15
期刊: Journal of neuroimmunology
影响因子: 3.3
作者: [Bilousova T, Dang H, Xu W, Gustafson S, Jin Y, Wickramasinghe L, Won T, Bobarnac G, Middleton B, Tian J, Kaufman DL]
通讯作者: Kaufman DL
DOI: 10.1371/journal.pone.0018439
发表时间: 2011-03-31
期刊: PloS one
影响因子: 3.7
作者: [Washburn LR, Zekzer D, Eitan S, Lu Y, Dang H, Middleton B, Evans CJ, Tian J, Kaufman DL]
通讯作者: Kaufman DL
Enhanced neuronal expression of major histocompatibility complex class I leads to aberrations in neurodevelopment and neurorepair.
主要组织相容性复合物I类的神经元表达增强导致神经发育和神经膜的畸变。
DOI: 10.1016/j.jneuroim.2010.09.009
发表时间: 2011-03
期刊: Journal of neuroimmunology
影响因子: 3.3
作者: [Wu ZP, Washburn L, Bilousova TV, Boudzinskaia M, Escande-Beillard N, Querubin J, Dang H, Xie CW, Tian J, Kaufman DL]
通讯作者: Kaufman DL
DOI: 10.4049/jimmunol.0902159
发表时间: 2010-01-15
期刊: Journal of immunology (Baltimore, Md. : 1950)
影响因子: --
作者: [Escande-Beillard N, Washburn L, Zekzer D, Wu ZP, Eitan S, Ivkovic S, Lu Y, Dang H, Middleton B, Bilousova TV, Yoshimura Y, Evans CJ, Joyce S, Tian J, Kaufman DL]
通讯作者: Kaufman DL
6
    Oral GABA treatment as a novel and safe therapy to ameliorate Sjögren’s syndrome
    Combination immunotherapy to preserve beta-cell function in the context of autoimmunity
    Combination immunotherapy to preserve beta-cell function in the context of autoimmunity
    Reversal of T1D in NOD mice using a safe combination therapy
    海外基金